<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study aims to assess the protective role of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme catalase (CAT) with relation to <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> (<z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>) degradation in oxygen plus water on electrophysiological and fluorescence changes induced by in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and on brain damage produced by transient in vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Neuroprotective effects of CAT were determined by means of electrophysiological recordings and confocal fluorescence microscopy in the hippocampal slice preparation </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> was simulated in vitro by oxygen/<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD) </plain></SENT>
<SENT sid="3" pm="."><plain>In vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was produced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) </plain></SENT>
<SENT sid="4" pm="."><plain>A protection of the rat CA1 field excitatory postsynaptic potential (fEPSP) loss caused by a prolonged OGD (40 min) was observed after exogenous CAT (500 U/mL) bath-applied before a combined exposure to OGD and <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> (3 mM) </plain></SENT>
<SENT sid="5" pm="."><plain>Of note, neither <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> nor exogenous CAT alone had a protective action when OGD lasted for 40 min </plain></SENT>
<SENT sid="6" pm="."><plain>The CAT-induced neuroprotection was confirmed in a transgenic mouse model over-expressing human CAT [Tg(CAT)] </plain></SENT>
<SENT sid="7" pm="."><plain>In the presence of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>, the hippocampus of Tg(CAT) showed an increased resistance against OGD compared to that of <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) animals </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, CAT treatment reduced for about 50 min fEPSP <z:hpo ids='HP_0000716'>depression</z:hpo> evoked by repeated applications of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> in normoxia </plain></SENT>
<SENT sid="9" pm="."><plain>A lower sensitivity to <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>-induced <z:hpo ids='HP_0000716'>depression</z:hpo> of fEPSPs was also indicated by the rightward shift of concentration-response curve in Tg(CAT) compared to WT mice </plain></SENT>
<SENT sid="10" pm="."><plain>Noteworthy, Tg(CAT) mice had a reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size after MCAo </plain></SENT>
<SENT sid="11" pm="."><plain>Our data suggest new strategies to reduce neuronal damage produced by transient <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> through the manipulation of CAT enzyme </plain></SENT>
</text></document>